www.polytech-antibes.fr

Pristiq

Before pfizer bought wyeth in 2009, wyeth allegedly withheld from shareholders information about pristiq s adverse effects in the class period beginning june 26, 2006, and ending july 24, 2007, when the fda declined to approve pristiq for treating hot flashes. Continuer la lecture